Dividend Tempts, But Fog Cloaks Pfizer's Outlook

Dividend Tempts, But Fog Cloaks Pfizer's Outlook: "Sales of its smoking-cessation drug Chantix grew 773% in 2007. But that carries a qualifier. On Feb. 1, the FDA issued an advisory on Chantix, claiming that it had been linked to severe mood changes." [CNN]